2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Pancreatic Neoplasms
16
Multiple Myeloma
13
Neoplasms
12
Colorectal Neoplasms
8
Neoplasms, Plasma Cell
7
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Skin Neoplasms
3
Inflammation
3
Colonic Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Interventions
pembrolizumab
157
Gemcitabine
140
Capecitabine
123
Paclitaxel
121
Fluorouracil
117
Oxaliplatin
110
Bevacizumab
106
Nivolumab
99
Docetaxel
98
Leucovorin
97
Cisplatin
90
Radiosurgery
88
Irinotecan
88
Carboplatin
86
Cyclophosphamide
72
Cetuximab
72
Magnetic Resonance Spectroscopy
68
Specimen Handling
60
Radiotherapy
60
Trastuzumab
59
Biopsy
59
Ipilimumab
53
Drug Therapy
51
Everolimus
48
Pemetrexed
46
Albumin-Bound Paclitaxel
45
130-nm albumin-bound paclitaxel
44
Doxorubicin
42
Fulvestrant
40
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Ascorbic Acid
×
Clear all
NCT04150042
2026-01-29
SHARON
General Oncology, Inc.
Phase 1
Recruiting
24 enrolled